Last reviewed · How we verify
IV Meperidine
At a glance
| Generic name | IV Meperidine |
|---|---|
| Also known as | Pethidine |
| Sponsor | HaEmek Medical Center, Israel |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Postoperative Analgesia and Ventilation After Cardiac Surgery
- E7 TCR T Cells for Human Papillomavirus-Associated Cancers (PHASE1, PHASE2)
- Interscalene Block vs Serratus Posterior Superior Intercostal Plane Block (NA)
- Erector Spinae Plane Block vs Quadratus Lumborum Block for Laparoscopic Nephrectomy (NA)
- Ultrasound-Guided Adductor Canal Block for Total Knee Arthroplasty Surgery (NA)
- Combined Intravenous Tramadol and Paracetamol Versus Intramuscular Pethidine for Pain Relief During the First Stage of Labor. Compare the Efficacy and Adverse Effects (NA)
- T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers (PHASE1)
- Para-sartorial Compartment Block in Knee Surgery (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- IV Meperidine CI brief — competitive landscape report
- IV Meperidine updates RSS · CI watch RSS
- HaEmek Medical Center, Israel portfolio CI